| UnitedHealthcare |
| Truseltiq (100MG Daily Dose) (infigratinib) |
| Drugs for Cancer : Drugs for Cancer |
- PA Applies
- Prior Authorization: PIK3CA-Related Overgrowth Spectrum (PROS):
Documented Diagnosis: Yes
Medical Test Required: Yes
Age Requirement: >= 2
Duration: 6 Month(s)
Reauthorization Required: Yes
|